News Releases

Date	Title	Document
Date Jul 27, 2018	Title OncoCyte Announces At-Market $3.59 Million Offering of Common Stock and Warrants	Document PDF
Date Jul 09, 2018	Title OncoCyte Reports Encouraging New Study Results for Lung Cancer Blood Test	Document PDF
Date May 15, 2018	Title OncoCyte Reports First Quarter 2018 Financial Results	Document PDF
Date May 08, 2018	Title OncoCyte to Report First Quarter 2018 Financial Results on May 15, 2018	Document PDF
Date Apr 03, 2018	Title Leading Molecular Diagnostics Executive Ronnie Andrews Appointed to OncoCyte’s Board of Directors	Document PDF
Date Apr 02, 2018	Title OncoCyte Reports Fourth Quarter and Full Year 2017 Financial Results	Document PDF
Date Apr 02, 2018	Title OncoCyte Files Patents for 190 Newly Identified Novel Lung Cancer Biomarkers	Document PDF
Date Apr 02, 2018	Title OncoCyte Names Cavan Redmond Chairman of the Board of Directors	Document PDF
Date Mar 29, 2018	Title OncoCyte to Report Fourth Quarter and Full Year 2017 Financial Results on April 2, 2018	Document PDF
Date Mar 28, 2018	Title OncoCyte Announces the Closing of a $10 Million Private Placement of Common Stock	Document PDF